Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer-Reference-Cited by-同舟云学术

Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer

Published:2017-02 Issue:1 Volume:15 Page:145-151.e2
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Buisan Oscar^ORCID,Orsola Anna,Areal Joan,Font Albert,Oliveira Mario,Martinez Roberto,Ibarz Luis

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference33 articles.

1. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients;Stein;J Clin Oncol,2001

2. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines;Witjes;Eur Urol,2014

3. Bladder cancer;Clark;J Natl Compr Canc Netw,2013

4. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration;Eur Urol,2005

5. Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides;Reardon;Eur Urol,2015

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of response to neoadjuvant therapy in urothelial cancer;Critical Reviews in Oncology/Hematology;2024-02

2. Systemic Inflammatory Index: A Promising Non-Invasive Marker for the Prediction of Response to Neoadjuvant Chemotherapy prior to Cystectomy;Urologia Internationalis;2024

3. Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy;Clinical Genitourinary Cancer;2023-08

4. Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab;International Journal of Clinical Oncology;2023-04-27

5. New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors;Journal for ImmunoTherapy of Cancer;2023-01